Opening stock page...
Fetching company snapshot, pricing, and intelligence.
ORIC has basic price and filing data (40% intelligence coverage), but earnings analysis, financial metrics, and proprietary signals are still building. Explore a peer with deeper coverage below.
Intelligence coverage: 40%
Basic profile, financials, and market data are shown below. Deep research is building in the background.
AI confidence 50% · prior close shown (market closed)
Limited proprietary earnings coverage for ORIC yet — signals will sharpen as filings and earnings are ingested.
Pipeline evidence · 17d ago
ORIC's AlphaOS Signals
Upgrade to Pro for validated historical pattern analysis on ORIC.
Free accounts see more of this; Premium sees all of it.
Updated
What happened recently for Oric Pharmaceuticals, Inc. (ORIC) — events, not interpretation.
Research & analysis only — not investment advice.
Held in ETFsweight · est. sleeve dollars
Investment snapshot
ORIC's AI investment thesis
Upgrade to Premium for ORIC's full multi-agent investment thesis.
Free accounts see more of this; Premium sees all of it.
Unified data coverage and cross-signal highlights — market, SEC, earnings, opportunity
Strengthen intelligence
Prior close
$13.50
Market cap
$1.40B
Profitable
—
Net income
—
FY Sep 12, 2026
Loading Wall Street consensus…
Loading earnings intelligence…
Building technical intelligence snapshot — check back shortly.
Loading market context…
No price history. Sync market data to load charts.
Loading SEC filing intelligence…
No filings ingested yet.
Investment Snapshot above is the primary AlphaOS analysis for Oric Pharmaceuticals, Inc. — structured signals and evidence from proprietary pipelines, not an encyclopedia overview.
Research & analysis only — not investment advice. Price, charts, and filings are above.
Follow Oric Pharmaceuticals, Inc. through AlphaOS's knowledge graph — themes, peers, beneficiaries, earnings, and research answers.
Connected companies and research pages from the AlphaOS knowledge graph.